Business Description
Sanai Health Industry Group Co Ltd
ISIN : KYG7785S1075
Description
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.32 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | 2.56 | |||||
| Interest Coverage | 10.42 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.13 | |||||
| Beneish M-Score | -4.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -9.1 | |||||
| 3-Year EBITDA Growth Rate | 2.2 | |||||
| 3-Year EPS without NRI Growth Rate | 29.8 | |||||
| 3-Year Book Growth Rate | 7.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 2.59 | |||||
| 9-Day RSI | 10.57 | |||||
| 14-Day RSI | 17.01 | |||||
| 6-1 Month Momentum % | -71.43 | |||||
| 12-1 Month Momentum % | -77.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.23 | |||||
| Quick Ratio | 6.22 | |||||
| Cash Ratio | 5.62 | |||||
| Days Inventory | 3.79 | |||||
| Days Sales Outstanding | 48.45 | |||||
| Days Payable | 26.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | 3.89 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.82 | |||||
| Operating Margin % | 17.51 | |||||
| Net Margin % | 15.26 | |||||
| FCF Margin % | 262.59 | |||||
| ROE % | 7.22 | |||||
| ROA % | 4.82 | |||||
| ROIC % | 7.5 | |||||
| 3-Year ROIIC % | -0.32 | |||||
| ROC (Joel Greenblatt) % | 15.8 | |||||
| ROCE % | 8.01 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 1.76 | |||||
| PE Ratio without NRI | 1.76 | |||||
| Price-to-Owner-Earnings | 0.1 | |||||
| PS Ratio | 0.28 | |||||
| PB Ratio | 0.11 | |||||
| Price-to-Tangible-Book | 0.11 | |||||
| Price-to-Free-Cash-Flow | 0.11 | |||||
| Price-to-Operating-Cash-Flow | 0.11 | |||||
| EV-to-EBIT | -9.85 | |||||
| EV-to-EBITDA | -9.85 | |||||
| EV-to-Revenue | -1.97 | |||||
| EV-to-FCF | -0.74 | |||||
| Price-to-Median-PS-Value | 0.14 | |||||
| Price-to-Graham-Number | 0.09 | |||||
| Price-to-Net-Current-Asset-Value | 0.11 | |||||
| Price-to-Net-Cash | 0.13 | |||||
| Earnings Yield (Greenblatt) % | -10.16 | |||||
| FCF Yield % | 1001.21 | |||||
| Forward Rate of Return (Yacktman) % | 631.45 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers